Double-phase transition and giant positive magnetoresistance in the quasi-skutterudite Gd3_3Ir4_4Sn13_{13}

The magnetic, thermodynamic and electrical/thermal transport properties of the caged-structure quasi-skutterudite Gd$_3$Ir$_4$Sn$_{13}$ are re-investigated. The magnetization $M(T)$, specific heat $C_p(T)$ and the resistivity $\rho(T)$ reveal a double-phase transition -- at $T_{N1}\sim$ 10~K and at $T_{N2}\sim$ 8.8~K -- which was not observed in the previous report on this compound. The antiferromagnetic transition is also visible in the thermal transport data, thereby suggesting a close connection between the electronic and lattice degrees of freedom in this Sn-based quasi-skutterudite. The temperature dependence of $\rho(T)$ is analyzed in terms of a power-law for resistivity pertinent to Fermi liquid picture. Giant, positive magnetoresistance (MR) $\approx$ 80$\%$ is observed in Gd$_3$Ir$_4$Sn$_{13}$ at 2~K with the application of 9~T. The giant MR and the double magnetic transition can be attributed to the quasi-cages and layered antiferromagnetic structure of Gd$_3$Ir$_4$Sn$_{13}$ vulnerable to structural distortions and/or dipolar or spin-reorientation effects. The giant value of MR observed in this class of 3:4:13 type alloys, especially in a Gd-compound, is the highlight of this work.Comment: 20 pages single column, 7 figures, 1 table; Accepted to J. Appl. Phys., 201

Tuning the Electronic and Magnetic Properties of Nitrogen-Functionalized Few-Layered Graphene Nanoflakes

In this work, we report on the modification of electronic and magnetic properties of few layered graphene (FLG) nanoflakes via nitrogen functionalisation carried out using radio frequency (rf-PECVD) and electron cyclotron resonance (ECR) plasma processes. Even though the rf-PECVD N2 treatment leads to higher N-doping levels in the FLGs (4.06 at%) as compared to the ECR process (2.18 at.%), the ferromagnetic behaviour of ECR FLG(118.62 x 10⁻⁴ emu/gm) was significantly higher than the rf-PECVD (0.39 x 10⁻⁴ emu/gm) and pristine graphene (3.47 x 10⁻⁴ emu/gm). While both plasma processes introduce electron donating N-atoms in the graphene structure, distinct dominant nitrogen bonding configurations (pyridinic, pyrrolic) were observed for each FLG type. While, the ECR plasma introduces more sp2 type nitrogen moieties, the rf-PECVD process led to the formation of sp3 coordinated nitrogen functionalities, as confirmed through Raman measurements. The samples further characterised using X-ray absorption near edge spectroscopy (XANES) and X-ray, ultraviolet photoelectron spectroscopies revealed an increased electronic density of states and a significantly higher concentration of pyrrolic groups in the rf-PECVD samples. Due to the formation of reactive edge structures and pyridinic nitrogen moieties, the ECR functionalised FLGs expressed highest saturation magnetisation behaviour with the lowest field hysteretic features. In comparison, the rf-PECVD samples, displayed the lowest saturation magnetisation owing to the disappearance of magnetic edge states and formation of stable non-radical type defects in the pyrrole type structures. Our experimental results thus provide new evidence to control the magnetic and electronic properties of few layered graphene nanoflakes via control of the plasma-processing route

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale:Comprehensive Assessment of Psychopathology in Down Syndrome

People with Down syndrome (DS) are prone to develop Alzheimer's disease (AD). Behavioral and psychological symptoms of dementia (BPSD) are core features, but have not been comprehensively evaluated in DS. In a European multidisciplinary study, the novel Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) scale was developed to identify frequency and severity of behavioral changes taking account of life-long characteristic behavior. 83 behavioral items in 12 clinically defined sections were evaluated. The central aim was to identify items that change in relation to the dementia status, and thus may differentiate between diagnostic groups. Structured interviews were conducted with informants of persons with DS without dementia (DS, n = 149), with questionable dementia (DS+Q, n = 65), and with diagnosed dementia (DS+AD, n = 67). First exploratory data suggest promising interrater, test-retest, and internal consistency reliability measures. Concerning item relevance, group comparisons revealed pronounced increases in frequency and severity in items of anxiety, sleep disturbances, agitation & stereotypical behavior, aggression, apathy, depressive symptoms, and eating/drinking behavior. The proportion of individuals presenting an increase was highest in DS+AD, intermediate in DS+Q, and lowest in DS. Interestingly, among DS+Q individuals, a substantial proportion already presented increased anxiety, sleep disturbances, apathy, and depressive symptoms, suggesting that these changes occur early in the course of AD. Future efforts should optimize the scale based on current results and clinical experiences, and further study applicability, reliability, and validity. Future application of the scale in daily care may aid caregivers to understand changes, and contribute to timely interventions and adaptation of caregiving

Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders.

Chromosomal copy-number variations (CNVs) are a class of genetic variants highly implicated in the aetiology of neurodevelopmental disorders, including intellectual disabilities (ID), schizophrenia and autism spectrum disorders (ASD). Yet the majority of adults with idiopathic ID presenting to psychiatric services have not been tested for CNVs. We undertook genome-wide chromosomal microarray analysis (CMA) of 202 adults with idiopathic ID recruited from community and in-patient ID psychiatry services across England. CNV pathogenicity was assessed using standard clinical diagnostic methods and participants underwent comprehensive medical and psychiatric phenotyping. We found an 11% yield of likely pathogenic CNVs (22/202). CNVs at recurrent loci, including the 15q11-q13 and 16p11.2-p13.11 regions were most frequently observed. We observed an increased frequency of 16p11.2 duplications compared with those reported in single-disorder cohorts. CNVs were also identified in genes known to effect neurodevelopment, namely NRXN1 and GRIN2B. Furthermore deletions at 2q13, 12q21.2-21.31 and 19q13.32, and duplications at 4p16.3, 13q32.3-33.3 and Xq24-25 were observed. Routine CMA in ID psychiatry could uncover ~11% new genetic diagnoses with potential implications for patient management. We advocate greater consideration of CMA in the assessment of adults with idiopathic ID presenting to psychiatry services